303 related articles for article (PubMed ID: 15979030)
1. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
Komen JC; Duran M; Wanders RJ
Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
[TBL] [Abstract][Full Text] [Related]
2. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
Xu F; Ng VY; Kroetz DL; de Montellano PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
[TBL] [Abstract][Full Text] [Related]
3. Omega-hydroxylation of phytanic acid in rat liver microsomes: implications for Refsum disease.
Komen JC; Duran M; Wanders RJ
J Lipid Res; 2004 Jul; 45(7):1341-6. PubMed ID: 15102880
[TBL] [Abstract][Full Text] [Related]
4. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
5. Identification of the cytochrome P450 enzymes responsible for the omega-hydroxylation of phytanic acid.
Komen JC; Wanders RJ
FEBS Lett; 2006 Jul; 580(16):3794-8. PubMed ID: 16782090
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
7. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
Wierzbicki AS
Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
[TBL] [Abstract][Full Text] [Related]
8. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.
Jansen GA; Mihalik SJ; Watkins PA; Moser HW; Jakobs C; Denis S; Wanders RJ
Biochem Biophys Res Commun; 1996 Dec; 229(1):205-10. PubMed ID: 8954107
[TBL] [Abstract][Full Text] [Related]
9. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
Watanabe K; Matsunaga T; Yamamoto I; Yashimura H
Drug Metab Dispos; 1995 Feb; 23(2):261-5. PubMed ID: 7736922
[TBL] [Abstract][Full Text] [Related]
11. Formation of 7 alpha- and 7 beta-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria.
Shoda J; Toll A; Axelson M; Pieper F; Wikvall K; Sjövall J
Hepatology; 1993 Mar; 17(3):395-403. PubMed ID: 8444412
[TBL] [Abstract][Full Text] [Related]
12. Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA.
Verhoeven NM; Schor DS; ten Brink HJ; Wanders RJ; Jakobs C
Biochem Biophys Res Commun; 1997 Aug; 237(1):33-6. PubMed ID: 9266824
[TBL] [Abstract][Full Text] [Related]
13. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
Pahan K; Khan M; Singh I
J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
[TBL] [Abstract][Full Text] [Related]
14. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
15. Disorders related to the metabolism of phytanic acid.
Stokke O; Skjeldal OH; Høie K
Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
[TBL] [Abstract][Full Text] [Related]
16. The metabolic basis of the Refsum syndrome.
Steinberg D
Birth Defects Orig Artic Ser; 1971 Feb; 7(1):42-52. PubMed ID: 4141910
[TBL] [Abstract][Full Text] [Related]
17. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
18. Heteroatom substitution shifts regioselectivity of lauric acid metabolism from omega-hydroxylation to (omega-1)-oxidation.
Alterman MA; Chaurasia CS; Lu P; Hanzlik RP
Biochem Biophys Res Commun; 1995 Sep; 214(3):1089-94. PubMed ID: 7575514
[TBL] [Abstract][Full Text] [Related]
19. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.
Mukherji M; Kershaw NJ; Schofield CJ; Wierzbicki AS; Lloyd MD
Chem Biol; 2002 May; 9(5):597-605. PubMed ID: 12031666
[TBL] [Abstract][Full Text] [Related]
20. Alcohol consumption enhances fatty acid omega-oxidation, with a greater increase in male than in female rats.
Ma X; Baraona E; Lieber CS
Hepatology; 1993 Nov; 18(5):1247-53. PubMed ID: 8225232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
